Literature DB >> 20228036

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

David M Cook, Kevin C J Yuen, Beverly M K Biller, Stephen F Kemp, Mary Lee Vance.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20228036     DOI： 10.4158/EP.15.S2.1

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  42 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.

Authors:  Kevin C J Yuen; Beverly M K Biller; Laurence Katznelson; Sharon A Rhoads; Michelle H Gurel; Olivia Chu; Valentina Corazzini; Kellie Spiller; Murray B Gordon; Roberto Salvatori; David M Cook
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

3.  Variation of the baseline characteristics and treatment parameters over time: an analysis of 15 years of growth hormone replacement in adults in the German KIMS database.

Authors:  I Kreitschmann-Andermahr; S Siegel; F Francis; M Buchfelder; H J Schneider; P H Kann; H Wallaschofski; M Koltowska-Häggström; G Brabant
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

4.  IGF-I levels reflect hypopituitarism severity in adults with pituitary dysfunction.

Authors:  Amit Tirosh; Yoel Toledano; Hiba Masri-Iraqi; Yoav Eizenberg; Gloria Tzvetov; Dania Hirsch; Carlos Benbassat; Eyal Robenshtok; Ilan Shimon
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

Review 5.  Diagnosis and treatment of growth hormone deficiency in adults.

Authors:  Atil Y Kargi; George R Merriam
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

6.  Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

Authors:  Amir H Hamrahian; Kevin C J Yuen; Murray B Gordon; Karen J Pulaski-Liebert; James Bena; Beverly M K Biller
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

7.  Hypopituitarism in patients with vasculotoxic snake bite envenomation related acute kidney injury: a prospective study on the prevalence and outcomes of this complication.

Authors:  Vishal Golay; Arpita Roychowdhary; Sanjay Dasgupta; Rajendra Pandey
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

Review 8.  Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.

Authors:  Kevin C J Yuen; Anthony P Heaney; Vera Popovic
Journal:  Endocrine       Date:  2016-01-05       Impact factor: 3.633

9.  Growth hormone and cortisol secretion in the elderly evaluated using the glucagon stimulation test.

Authors:  Ana Beatriz Winter Tavares; Ignácio Antônio Seixas-da-Silva; Diego H S Silvestre; Maria Fernanda Castelar Pinheiro; Mario Vaisman; Flávia Lucia Conceição
Journal:  Endocrine       Date:  2017-03-11       Impact factor: 3.633

10.  The impact of real practice inappropriateness and devices' inefficiency to variability in growth hormone consumption.

Authors:  F Spandonaro; M Cappa; R Castello; F Chiarelli; E Ghigo; L Mancusi
Journal:  J Endocrinol Invest       Date:  2014-08-08       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.